Dr. Farshad Guirakhoo, CSO, is speaking today about our unique therapeutic breast cancer vaccine ES2B-C001 at the Immuno-Oncology Summit! 💉 Don't miss this chance to learn more. More info: ow.ly/ZKtj50Rg9g2

#IOSummitUK #VaccinesWork #VaccinesSaveLives #Breastcancer

#ICYMI : A Glimpse into Our Innovative Vaccines for a Healthier World 🚀
Last week, our CEO Bent Frandsen presented ExpreS2ion Biotech @Aktiespararna Life Science-dagen
#VaccinesSaveLives #VaccinesWork #BreastCancerResearch #LifeSciences #InvestorConference
ow.ly/8KkM50RjPpz

Dr. Farshad Guirakhoo, CSO, will be speaking about our unique therapeutic breast cancer vaccine ES2B-C001 at the Immuno-Oncology Summit! 💉 Don't miss this chance to learn more. More info: ow.ly/ZKtj50Rg9g2

#IOSummitUK #VaccinesWork #VaccinesSaveLives #Breastcancer

Dr. Farshad Guirakhoo, CSO, will be speaking about our unique therapeutic breast cancer vaccine ES2B-C001 at the Immuno-Oncology Summit! 💉 Don't miss this chance to learn more. More info: ow.ly/ZKtj50Rg9g2

#IOSummitUK #VaccinesWork #VaccinesSaveLives #Breastcancer

🚀Exciting news ahead!
On April 1st to 4th, ExpreS2ion will be at the World Vaccine Congress WVC in Washington D.C. Our CSO, Farshad Guirakhoo, will be presenting ExpreS2ion and our #breastcancer vaccine candidate on April 3rd.
More info: ow.ly/VVjU50R28EN #WorldVaccineCongress

🚀Exciting news ahead!
On April 1st to 4th, ExpreS2ion will be at the World Vaccine Congress WVC in Washington D.C. Our CSO, Farshad Guirakhoo, will be presenting ExpreS2ion and our #breastcancer vaccine candidate on April 3rd.
More info: ow.ly/jBrJ50R28xV #WorldVaccineCongress

Did you know that S2 cells can produce viral vaccine antigens that are more effective than mammalian cells? They can modulate glycan shielding to elicit stronger immune responses, and are scalable/fast to develop. Learn more about this breakthrough: ow.ly/5KVP50QJkue 🦠💉👏

ExpreS2ion CFO Keith Alexander will present @ExpresionB to investors and potential investors. Check the Swiss Nordic Bio website: swissnordicbio.com/index.php/swis… - #vaccinessavelives #vaccineswork #breastcancerresearch #biotech @swissnordicbio #swissnordicbio

ExpreS2ion CFO Keith Alexander will present @ExpresionB to investors and potential investors. Registration is possible via the Swiss Nordic Bio website: swissnordicbio.com/index.php/swis…

Join CEO Bent Frandsen for a live update at 13.30hrs. at @Aktiespararna #StoraAktiedagen in Stockholm. You can stream the event live at: invitepeople.com/public/events/… #vaccinessavelives #vaccineswork #breastcancerresearch #biotech

Join CEO Bent Frandsen for a live update at @Aktiespararna #StoraAktiedagen in Stockholm. You can stream the event live or on demand aktiespararna.se/tv/live. Read more and register on Aktiespararna's website: aktiespararna.se/aktiviteter/st…

ExpreS2ion to present in investor and R&D events in March

news.cision.com/expres2ion-bio…

ExpreS2ion Biotech will release its 2023 year-end results on 8 February 2024. Later the same day at 10:00, CFO Keith Alexander will take a deeper dive into the results and achievements in a virtual live event. 🚀 Info and registration: ow.ly/OhkA50Qvpmu inderes.se #biotech

ExpreS2ion Biotech will release its 2023 year-end results on 8 February 2024. Later the same day at 10:00, CFO Keith Alexander will take a deeper dive into the results and achievements in a virtual live event. 🚀 Info and registration: inderes.dk/videos/expres2… inderes.se #biotech